TCR dynamics in human mature T lymphocytes lacking CD3 gamma.
The contribution of CD3gamma to the surface expression, internalization, and intracellular trafficking of the TCR/CD3 complex (TCR) has not been completely defined. However, CD3gamma is believed to be crucial for constitutive as well as for phorbol ester-induced internalization. We have explored TCR dynamics in resting and stimulated mature T lymphocytes derived from two unrelated human congenital CD3gamma-deficient (gamma(-)) individuals. In contrast to gamma(-) mutants of the human T cell line Jurkat, which were selected for their lack of membrane TCR and are therefore constitutively surface TCR negative, these natural gamma(-) T cells constitutively expressed surface TCR, mainly through biosynthesis of new chains other than CD3gamma. However, surface (but not intracellular) TCR expression in these cells was less than wild-type cells, and normal surface expression was clearly CD3gamma-dependent, as it was restored by retroviral transduction of CD3gamma. The reduced surface TCR expression was likely caused by an impaired assembly or membrane transport step during recycling, whereas constitutive internalization and degradation were apparently normal. Ab binding to the mutant TCR, but not phorbol ester treatment, caused its down-modulation from the cell surface, albeit at a slower rate than in normal controls. Kinetic confocal analysis indicated that early ligand-induced endocytosis was impaired. After its complete down-modulation, TCR re-expression was also delayed. The results suggest that CD3gamma contributes to, but is not absolutely required for, the regulation of TCR trafficking in resting and Ag-stimulated mature T lymphocytes. The results also indicate that TCR internalization is regulated differently in each case.
Torres
Pilar S
PS
Inmunología, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
Alcover
Andrés
A
Zapata
David A
DA
Arnaud
Jacques
J
Pacheco
Alberto
A
Martín-Fernández
José M
JM
Villasevil
Eugenia M
EM
Sanal
Ozden
O
Regueiro
José R
JR
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D017252:CD3 Complex / Q000096:biosynthesis* / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D002454:Cell Differentiation / Q000235:genetics / Q000276:immunology; D002461:Cell Line, Transformed; D015536:Down-Regulation / Q000187:drug effects / Q000235:genetics / Q000276:immunology; D017353:Gene Deletion; D006801:Humans; D007424:Intracellular Fluid / Q000276:immunology / Q000378:metabolism; D019169:Jurkat Cells; D008024:Ligands; D008213:Lymphocyte Activation / Q000187:drug effects / Q000235:genetics; D011499:Protein Processing, Post-Translational / Q000276:immunology; D017260:Receptor-CD3 Complex, Antigen, T-Cell / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000172:deficiency / Q000378:metabolism*; D018089:Superantigens / Q000494:pharmacology; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000911:Antibodies, Monoclonal; D017252:CD3 Complex; C452842:CD3 antigen, gamma chain; D008024:Ligands; D017260:Receptor-CD3 Complex, Antigen, T-Cell; D018089:Superantigens; D013755:Tetradecanoylphorbol Acetate